Cargando…
Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway
BACKGROUND: The natural compound asperosaponin VI has shown potential as an antidepressant, but how it works is unclear. Here, we explored its effects on mice exposed to chronic mild stress (CMS) and the underlying molecular pathways. METHODS: Mice were exposed to CMS for 3 weeks followed by asperos...
Autores principales: | Jiang, Xue, Yi, Saini, Liu, Qin, Su, Dapeng, Li, Liangyuan, Xiao, Chenghong, Zhang, Jinqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131532/ https://www.ncbi.nlm.nih.gov/pubmed/35610721 http://dx.doi.org/10.1186/s12974-022-02478-y |
Ejemplares similares
-
Asperosaponin VI inhibits LPS-induced inflammatory response by activating PPAR-γ pathway in primary microglia
por: Zhang, Jinqiang, et al.
Publicado: (2020) -
Transcriptome analysis reveals that jasmonic acid biosynthesis and signaling is associated with the biosynthesis of asperosaponin VI in Dipsacus asperoides
por: Xu, Jiao, et al.
Publicado: (2022) -
Therapeutic effects of asperosaponin VI in rabbit tendon disease
por: Wang, Kun, et al.
Publicado: (2022) -
Asperosaponin VI Injection Enhances Orthodontic Tooth Movement in Rats
por: Ma, Dan, et al.
Publicado: (2020) -
Hypoxia inducible factor-1α mediates the mechanism of the Hedgehog pathway in tendinopathy repair by Asperosaponin VI
por: Wang, Kun, et al.
Publicado: (2022)